Here’s what needs to happen before 5- to 11-year-olds can get the Pfizer vaccine.
Chicago police officers and supporters listened as John Catanzara, right, president of the Chicago Fraternal Order of Police, spoke last week during a protest at City Hall against a vaccination mandate for city employees.Credit…Scott Olson/Getty Images
CHICAGO — A judge in Chicago blocked the city on Monday from enforcing a Dec. 31 vaccine mandate for police officers until the issue can be addressed in arbitration. The ruling was a blow to Mayor Lori Lightfoot and a victory for a police union that has been engaged in an increasingly vitriolic battle with City Hall over the rule.
Judge Raymond W. Mitchell of the Cook County Circuit Court said that as unionized employees, police officers had a right to have their objections to the mandate heard by an arbitrator before the requirement takes effect. If an arbitrator were to rule against the city after the vaccine mandate was being enforced, the judge wrote, there would be little recourse for officers who got vaccinated under duress.
“An award of back pay or reinstatement cannot undo a vaccine,” Judge Mitchell wrote. “Nothing can.”
Across the country, police unions have fought requirements that their members get vaccinated, sometimes leading to fears of mass resignations, as in Los Angeles County, Calif., where the sheriff has warned of a potential exodus.
The opposition to vaccination mandates has come even though nearly 500 American law enforcement officers have died from work-related Covid-19 since the start of the pandemic, according to the Officer Down Memorial Page — far more than have died from any other work-related cause in the last two years. On Monday, thousands of New York City employees, including police officers, were placed on unpaid leave for failing to get vaccinated by the city’s deadline.
In Chicago, Judge Mitchell’s ruling left in place a requirement for officers to report their vaccination status to the city, which the police union has opposed, and to undergo regular testing if not vaccinated.
“The reporting obligation itself is a minimal intrusion particularly considering that police officers are already obligated to provide medical information to their employer,” the judge wrote.
About 71 percent of Chicago Police Department employees had reported their vaccination status to the city by last week, by far the lowest rate of any city department. Around 7,300 police employees said they were vaccinated, while about 1,700 said they were not. More than 3,000 others had not provided their status. John Catanzara, the president of the Fraternal Order of Police in Chicago, which represents rank-and-file officers, had suggested that his members ignore the order and risk discipline or loss of pay.
Ms. Lightfoot’s office said the mayor would address the ruling later on Monday. Mr. Catanzara did not immediately respond to a request for comment.
Though several million pediatric doses of Pfizer-BioNTech’s coronavirus vaccine should be available in the next few days, the vaccination program for children aged 5 to 11 in the United States will only start “running at full strength” in the second week of November, a top White House official said on Monday.
Jeffrey D. Zients, the administration’s pandemic response coordinator, said that the government will deliver several million doses to doctors’ offices, pharmacies, health clinics and other sites within the next couple of days. But he appeared to dampen expectations that all the pending orders that states have placed for pediatric vaccine would be filled right away.
“We are planning on some vaccinations towards the end of this week,” he said, adding that the government will deliver a total of 15 million doses “across the next week or so.”
There are 28 million children aged 5 to 11 in the United States. Surveys indicate that only about one in three parents will permit their children to be vaccinated immediately.
Mr. Zients, speaking at a White House briefing, said the government began shipping doses within minutes of the Food and Drug Administration’s authorization Friday afternoon of Pfizer-BioNTech vaccine on an emergency basis for young children. “We began the process of moving 15 million doses from Pfizer’s freezers and facilities to distribution centers,” he said. From there, officials said, they will be shipped to roughly 20,000 vaccination sites, including children’s hospitals, pharmacies, pediatrician’s offices and health clinics.
“More doses will be packed and shipped and delivered each and every day over the next week,” he said.
The pediatric rollout depends on recommendations from the Centers for Disease Control and Prevention, which sets vaccine policy. The agency often follows recommendations from its advisory panel of experts, which is meeting Tuesday on the subject of Pfizer doses for children 5 to 11 years old.
Mr. Zients said setbacks to Moderna’s hopes to offer its vaccine to adolescents and younger children would not affect the vaccination campaign, because the government was counting only on the Pfizer-BioNTech vaccine for those age groups. “We’re in great shape on supply,” he said. “We have more than enough vaccine for every child 5 to 11.”
Over the weekend, Moderna announced that it would delay asking for regulatory authorization of a half-dose of its vaccine for children aged 6 to 11. The company decided to pull back after regulators informed the company that they may not complete their review this year of Moderna’s earlier request to offer a full dose of its vaccine to adolescents 12 to 17.
Regulators cited concerns about the risks of myocarditis, a condition involving inflammation of the heart muscle.
The coronavirus is responsible for more than five million confirmed deaths around the world as of Monday, according to data from the Center for Systems Science and Engineering at Johns Hopkins University. Such a loss would wipe out almost the entire population of Melbourne, Australia, or most of the nation of Singapore.
Experts say that five million is an undercount. Many countries are unable to accurately record the number of people who have died from Covid-19, like India and African nations; experts have questioned the veracity of data from other countries, like Russia.
“All of these estimates still rely on data being available, or someone going and collecting it before antibodies and local memories wane,” said Adam Kucharski, an associate professor at the London School of Hygiene & Tropical Medicine who mathematically analyzes infectious disease outbreaks. “Globally, there will have been numerous local tragedies going unreported.”
The real number of people lost to Covid-19 could be underestimated by “a multiple of two to 10” in some nations, said Denis Nash, an epidemiologist at the City University of New York Graduate School of Public Health and Health Policy. Overall, he said, the true global toll could be as high as twice the reported figure (not up to 10 times, as an earlier version of this item incorrectly implied).
The pace of confirmed deaths seems to have slowed slightly since the world reached four million in early July, despite the rapid spread of the Delta variant since then — a sign that the spread of vaccines could be having an impact, at least in some parts of the world. It took nine months for the virus to kill one million people, three and a half more to reach two million, another three to claim three million and about two and a half to exceed four million.
The United States leads all other countries, with more than 745,000 deaths confirmed in total. The nations with the highest reported death tolls after the United States are, in order, Brazil, India, Mexico and Russia.
The global rate of reported deaths climbed over the past two weeks after trending downward for much of September and the first half of October, but at an average of over 7,000 deaths per day remains about 3,000 less than its August peak. The World Health Organization said last week in a report on pandemic conditions that confirmed deaths had increased in Europe and Southeast Asia, and declined in parts of Africa, the Middle East and Asia.
Dr. Nash said that the death rate appeared to be slowing “in places around the world where we are doing a good job at counting deaths, which also happen to be places in the world that have the best access to vaccines.”
But, he continued, “I think there are places where there are increases in the death rates, but we’re just not measuring them.”
The 20 countries that have recorded the most reported deaths per capita in recent weeks are mostly in Eastern Europe and the Caribbean, and most of them have vaccinated far less than half of their populations.
Coronavirus cases are rising in Europe, even though three-quarters of the European Union’s adult population has been fully vaccinated. Those inoculation rates plummet in countries like Bulgaria and Romania, and are even lower in nations that are outside of the bloc, like Armenia.
That vaccination gap persisted even when shots became more widely available. A September report on perceptions of the pandemic by the European Council on Foreign Relations said that the disparity seemed to be driven largely by misinformation, distrust and skepticism.
Vaccine hesitancy is also a major problem for Caribbean nations, and many of them also face unequal distribution of doses and logistical hurdles, the W.H.O. said in October.
W.H.O. officials have pressed wealthy nations to provide more vaccines to poorer ones. They and others have decried vaccine hoarding and most booster shot programs when much of the world has yet to be inoculated. Worldwide, about 76 percent of shots that have been administered have been so in high- and upper-middle-income countries, according to the Our World in Data project at the University of Oxford. Only 0.6 percent of doses have been administered in low-income countries.
Dr. Nash said he was hopeful that expanded access to vaccines and new pharmaceutical treatments, including an antiviral pill by Merck, would eventually rein in the virus.
Dr. Kucharski said that the actual number of dead would not be known for a long time.
“People need to be aware that it may take years to truly understand the toll of Covid-19,” he said.
New York City started to enforce its Covid vaccine mandate for municipal workers on Monday, and about 9,000 workers who refused to get vaccinated were placed on unpaid leave.
Mayor Bill de Blasio said on Monday that the vaccination rate for city workers continued to climb, reaching 91 percent, and that the city was running smoothly despite the absences.
“We’re not seeing disruptions to any city services,” he said, before urging workers to get vaccinated and return to work.
City officials said that they were coping with the reduction in workers without a significant slowdown of city services. With measures like shuffling firefighters between companies and extending the workday for sanitation workers, city agencies have been shoring up coverage.
Unvaccinated municipal employees without an approved medical or religious exemption — or a pending request for one — were placed on unpaid leave.
The number of vaccinated workers at city agencies has surged in the last few days, including at the New York Police Department, where 85 percent of employees were vaccinated on Monday, up from 70 percent when the mandate was announced.
Police Commissioner Dermot Shea said on Monday that placing unvaccinated officers on unpaid leave was having “literally no effect on service at this point.”
The city has a total of about 378,000 workers; about 6 percent remain unvaccinated, including those put on unpaid leave and about 12,000 workers who have applied for a medical or religious exemption. Those seeking exemptions are allowed to continue to work, while being tested weekly, until their cases are decided.
At the New York Police Department, officials had recently estimated that as many as 2,500 employees could be placed on leave on Monday as the department begins enforcing the vaccine mandate, according to a high-ranking official, who added that the number was falling because some personnel were getting immunized at the last minute.
The Police Department, which has about 36,000 uniformed officers and 19,000 civilian employees, was confident that it could manage the absences without taking measures such as canceling days off and moving to 12-hour shifts, said the official, who was not authorized to speak publicly.
The Sanitation Department has put workers on 12-hour shifts and told many to plan to come in on Sundays.
The vaccine mandate has been especially contentious within the tight-knit Fire Department. More than 2,000 New York City firefighters — out of a total uniformed force of about 11,000 — have taken sick days over the past week in what city officials describe as a large-scale protest against the mandate.
“Irresponsible bogus sick leave by some of our members is creating a danger for New Yorkers and their fellow firefighters,” the fire commissioner, Daniel A. Nigro, said in a statement. He attributed the uptick in sick leave to “anger at the vaccine mandate.”
The personnel shortage has put a strain on Fire Department operations. The department said that all its firehouses remained open, but that maintaining coverage across the city had required shuffling personnel around to reconstitute fire companies.
Andrew Ansbro, president of the Uniformed Firefighters Association, the union that represents rank-and-file firefighters, said that there had been no organized sickout. But hundreds of firefighters were feeling the side effects of vaccine doses and were too unwell to work, Mr. Ansbro said in a phone interview Sunday morning. “Hundreds of guys are feeling flulike symptoms, because that’s what the shot does to people,” Mr. Ansbro said.
The number of employees with approved exemptions — or pending ones — is unclear. But it could be that the number of people placed on unpaid leave on Monday is relatively small compared with the number that go on leave in the days ahead — should those applications for exemptions be mostly rejected.
The Police Department, for instance, has received applications for exemptions for some 6,500 officers, according to the official. Over the next two weeks, the department is expected to decide most of those cases, the official said, adding that a large portion of the requests would most likely be denied.
Organizing a global summit with leaders from more than 100 nations and tens of thousands of delegates and activists — while preparing for more than 100,000 protesters to fill the streets outside the conference halls — would be a daunting challenge at any time.
This is not any time. With the coronavirus still stalking the planet, officials at this year’s COP26 climate summit, already delayed a year because of the pandemic, are under pressure to address the dangers posed by a warming planet even as the invisible threat of the virus looms. As the summit kicked off, the official global virus death toll passed five million.
And just as the changing climate has already had some of the most devastating consequences on the world’s poorest nations, the failure to equitably distribute lifesaving vaccines has left the world divided between the protected and the exposed.
Vaccine inequity is also having an impact on the summit, with activists saying that the voices from some of the nations most affected by climate change are not being properly represented.
Dorothy Guerrero, of the advocacy group Global Justice Now, told reporters over the weekend that the refusal to give more manufacturers access to produce the vaccines was part of the reason that some delegates from developing nations were unable to attend.
“You are already saddled by the fact that your country was affected already for many decades, and you are the least responsible for this climate change,” she said at a news conference in Glasgow. “Yet you could not come here and raise your voice in this important meeting simply because you don’t have access to the vaccine.”
Britain offered to help any delegates who need a Covid-19 vaccination obtain one, but attendees are not required to be inoculated. Instead, delegates must show proof of a negative coronavirus test every day to be admitted to the conference center.
Kristy Swanson, an actress who is a vocal vaccine skeptic and critic of Dr. Anthony Fauci, has been hospitalized with virus-related pneumonia in New Jersey, she said.
The actress, who is best known for playing the titular character in the 1992 film “Buffy the Vampire Slayer,” was taken by ambulance on Sunday to Virtua Memorial Hospital in Mount Holly, N.J., she said on Twitter on Monday. She said she had pneumonia and was being treated with oxygen, blood thinners and baricitinib, an arthritis drug that the Food and Drug Administration in July granted emergency authorization to treat Covid.
She said on Monday that she was “in good spirits” but was receiving treatments “so I don’t clot.”
“I was just at the tail end of my Covid diagnosis when it jumped into my lungs,” she said on Twitter.
Although it was not clear if Ms. Swanson, 51, has received a Covid vaccine, she has frequently criticized proponents of the vaccine. In September, she said on Twitter, alongside an article about Covid, that “it behaves just like the flu.”
Every year there is a new strain of the flu and “a new vaccine comes out for it,” she said. “That’s exactly what this whole thing is, except this time they want to mandate vaccines so they can make mo-money.”
On Monday afternoon, she said on Twitter: “Fact Check: I have NEVER said I am anti-vax.”
Ms. Swanson has been a vocal supporter of President Donald Trump and met him in the Oval Office in February last year. She has directed several critical tweets at Dr. Fauci, the top U.S. infectious disease official.
Thailand reopened on Monday to fully vaccinated tourists arriving by air from 63 countries as it strives to revive its economy despite struggling to reduce Covid-19 case numbers.
Bangkok also lifted its nighttime curfew, which had been in place for four months, and will allow some restaurants to resume serving alcohol. Bars, nightclubs and entertainment venues will remain closed at least until December.
With the moves, Thailand became one of the first countries in Southeast Asia to reopen to tourists without requiring quarantine. Singapore opened in September to tourists from two countries without quarantine and has expanded its list to 10.
Indonesia opened Bali and two other islands last month but imposed so many restrictions, including four nights of quarantine, that foreign tourists have yet to arrive. Cambodia and Vietnam plan to reopen selected areas to foreign tourists at the end of November.
About a fifth of Thailand’s economy depends on tourism and, before the pandemic, it was one of the world’s top tourist destinations, drawing nearly 40 million visitors in 2019. People who depend on tourism for a living said that they were desperate for business and welcomed the prospect of foreigners returning.
“I am optimistic that by opening the country, our economic condition will improve,” said Rujira Komonsing, owner of a shoe shop in Bangkok’s sprawling Chatuchak market. “I see that we have to live with Covid. The disease will not go away.”
The government is reopening now, in time for the coming peak tourism season, even though it is struggling to contain a monthslong outbreak. On Monday, it reported 8,165 new cases. But merchants and tourism industry workers said that going hungry was a greater risk than Covid.
“I am not worried about the number of cases,” said Puncharee Wongraungaram, a ceramics vendor at Chatuchak, once a popular tourist destination. “We can’t afford to close the country any longer. People have expenses to pay and need to eat.”
The list of 63 points of origin that Thailand has deemed to be low risk includes the United States, China, India, Southeast Asia and much of Europe.
Fully vaccinated visitors from those areas will not have to undergo quarantine but must take a P.C.R. test on arrival and stay one night in an approved hotel while awaiting the result. If they test negative, they can travel around the country.
After a slow start in obtaining vaccines, Thailand’s reopening has followed an aggressive inoculation campaign, especially in popular tourist areas. Bangkok reports that about two-thirds of its population is fully vaccinated.
After being separated from his parents for two years, Jimmy Sugandi, 42, touched down on Monday in Melbourne, Australia, after traveling from Indonesia with his wife and two young children.
“It’s unbelievable,” he said. “We thought we were never coming back.”
Mr. Sugandi and his family are Australian permanent residents who live in Indonesia. During the pandemic, he tried to travel to Melbourne to see his parents, who live in the city. But Mr. Sugandi couldn’t get a spot on one of the extremely limited flights because of Australia’s strict border restrictions.
Tens of thousands of Australians have been stranded overseas by the border rules brought in by their country about 18 months ago to combat the coronavirus pandemic. But on Monday, the states of New South Wales, which includes Sydney, and Victoria, which includes Melbourne, lifted restrictions on citizens and permanent residents seeking to return. For the first time since the start of the pandemic, Australians are also now able to leave the country without needing to be granted an exemption from the government.
New South Wales and Victoria are allowing vaccinated Australians to return without quarantining. The states are also removing the caps on the number of citizens allowed to fly back into the country each week, which had previously made it difficult to obtain airline tickets.
The moves come a little over a week after Melbourne lifted one of the world’s longest cumulative lockdowns.
Other Australian states remain largely closed, both to overseas visitors and to Australians returning from abroad or traveling from other states in the country.
At Melbourne airport, the first international flight to touch down was from Singapore. Families reunited with tears and kisses as airport staff handed out bouquets of flowers.
After 21 months apart, Kirsty Rae, 57, and Keely Briggs, her 25-year-old daughter, embraced.
“It’s been pretty surreal,” said Ms. Briggs, who returned from South Korea, where she had been working as a teacher, via a flight from Hong Kong. “It’s been really difficult to get back,” she noted.
“I want to confiscate her passport so she doesn’t take off again,” her mother said with a laugh.
Joy and relief were tempered by reminders of important moments missed and lives upended.
Elva Duan, who spent 18 months away, returned from Hong Kong with three young children in tow. Her husband was to pick them up outside the airport, and the children grabbed at her clothes and clamored: “Where’s daddy? Is daddy here yet?”
Ms. Duan said that her youngest son was only a few months old when they left Australia. “Now he knows how to run, how to walk, how to speak,” she said.More news from around the world:
Fully vaccinated tourists from 63 countries can now travel by air to Thailand, an effort to revive the country’s economy while it struggles to lower coronavirus case numbers. Bangkok also lifted its nighttime curfew and will allow some restaurants to serve alcohol, though bars, nightclubs and entertainment venues will remain closed at least until December.
Greece reported a record 5,449 new coronavirus cases on Monday, weeks after the government lifted some pandemic restrictions, mainly for vaccinated people. The spike in cases has led the authorities to consider introducing more restrictions for the unvaccinated or reimposing some precautions in areas where infection levels are highest, like Northern and Central Greece.
A seven-day lockdown will begin on Tuesday on Tongatapu, the largest island in Tonga, according to the news outlet Matangi Tonga. The lockdown was prompted by the remote Pacific nation’s first positive coronavirus test, which was discovered last week.
Many vaccinated foreign nationals are now allowed to enter Israel through Ben-Gurion International Airport, the ministry of tourism said on its website. Vaccinated visitors must still comply with a number of rules.
Novavax, a Maryland-based company that received $1.75 billion from the United States government to develop a protein-based Covid-19 vaccine, announced Monday it had won emergency authorization for its vaccine in Indonesia.
After months of production delays, this is the first authorization for Novavax and its manufacturing partner, the Serum Institute of India. They have also applied for clearance in India and the Philippines, and Novavax has applied on its own to other countries, including Britain and Canada.
In its Monday announcement, Novavax said it would be submitting an application to the U.S. Food and Drug Administration by the end of the year.
In a statement, Stanley C. Erck, Novavax’s president and chief executive, said that the green light from Indonesia “is the first of many authorizations that Novavax expects in the coming weeks and months for our vaccine globally.”
Novavax’s vaccine is fundamentally different from the Covid-19 vaccines now authorized in the United States from Johnson & Johnson, Moderna and Pfizer-BioNTech. It consists of microscopic particles studded with viral proteins, mixed with an immune-boosting compound called an adjuvant.
In clinical trials in the United States and elsewhere, Novavax’s vaccine proved highly effective. But the company has struggled to ramp up its manufacturing and demonstrate the purity of its vaccines to regulators.
As a result, Novavax fell behind other vaccine developers supported by Operation Warp Speed, the Trump administration’s program to expedite Covid vaccines, missing the first wave of vaccinations in the United States. If authorized in the United States, Novavax might potentially serve as a booster for people who have gotten other vaccines as their primary doses.
Since last year, Novavax was also expected to make up a large portion of the vaccines that would be distributed globally. In February, it announced an agreement to supply 1.1 billion doses to Covax, an initiative to deliver vaccines to low and middle-income countries. In September, Covax had to cut its projected delivery of doses in 2021 by a quarter, in part because Novavax had yet to win authorization for its vaccine.
Indonesia initially began vaccinating its citizens with vaccines from China, but a bout of breakthrough infections among health care workers raised concerns that their immunity had waned quickly. The country subsequently made deals to secure doses from Novavax, as well as Pfizer-BioNTech, AstraZeneca and Moderna.
Indonesia has secured 320 million total doses through these deals, including 50 million from Novavax. Once those vaccines are delivered, they will be enough for 160 million people in a country of 237 million.
So far, only 43 percent of people in Indonesia have received at least one dose, while almost 27 percent are fully vaccinated.
Winning authorization in Indonesia will not on its own enable Novavax to live up to its promises to Covax. Covax accepts vaccines that have won authorization from the World Health Organization or a country that it recognizes as having stringent regulations. Indonesia is not on that list.
Federal regulators are reviewing data on the link between Moderna’s coronavirus vaccine and a rare heart problem in adolescents, the company announced on Sunday. That side effect — myocarditis, an inflammation of the heart muscle — has also worried advisers to federal agencies in deliberations regarding use of the Pfizer-BioNTech vaccine in younger children and teenagers.
Scientists advising the Centers for Disease Control and Prevention will review the latest data on the condition at a meeting on Tuesday before deciding whether to recommend the Pfizer-BioNTech vaccine for younger children.
So how common is myocarditis? And should parents be concerned about vaccinating their children?
Absolutely not, said several experts familiar with the recent studies. While the vaccines made by Pfizer-BioNTech and Moderna do seem to be associated with an increased risk of myocarditis, the absolute risk remains very small. Most cases are mild and resolve quickly.
Myocarditis generally results from infection with a virus or bacteria, and causes symptoms like rapid or irregular heartbeat, chest pain and shortness of breath. Globally, about 10 to 20 people out of every 100,000 develop myocarditis each year, but many others have mild symptoms and may never be diagnosed.
Since the start of the coronavirus pandemic, tens of thousands of U.S. children have been hospitalized with Covid-19, and 657 have died, according to data collected by the C.D.C.
Some children who are infected with the coronavirus may go on to develop long Covid, remaining ill for months after the initial infection is gone, or multisystem inflammatory syndrome, which has affected at least 5,200 children in the United States.
The myocarditis linked to the vaccines is far less frequent and severe compared with that observed in patients with Covid, and it does not seem to cause lasting harm, said Dr. James de Lemos, a cardiologist at the University of Texas Southwestern Medical Center in Dallas.
The coronavirus can infect cardiac muscle, as well as the lining of blood vessels, putting the heart and other organs at risk of long-term damage. The virus can also weaken the heart enough to require a transplant, and even cause lethal damage.
The Biden administration will release the highly anticipated details of a federal vaccine mandate for private employers “in coming days,” a representative for the Department of Labor said Monday. When the details become public, a flurry of corporate vaccine mandates is expected to follow.
President Biden instructed the Department of Labor and its Occupational Safety and Health Administration in September to draft an emergency temporary standard requiring businesses with 100 or more employees to mandate vaccinations against the coronavirus or weekly testing. The process has been particularly painstaking given likely legal challenges to the rule.
The Office of Management and Budget completed its review of the rule on Monday, the Labor Department representative said. It will now go to the Federal Register for review, which will publish it “in the coming days,” the representative said.
The Department of Labor has received comments on the mandate from trade groups, including the Chamber of Commerce, as well as executives from companies like UPS, the Walt Disney Company, Fidelity Investments. Many companies have a long list of questions about how the requirement will work, including who will pay for testing associated with the mandate and how the federal government will track compliance.
Some companies, like 3M, Procter & Gamble, IBM, American Airlines, Alaska Airlines and JetBlue, have already moved forward with vaccine mandates, but others have said they are awaiting more details from the federal government.
Noam Scheiber contributed reporting.
As cultural institutions come back to life this fall after the long pandemic shutdown, many are trying to lure audiences back with shorter shows, often free of intermissions.
The Metropolitan Opera is taking a different tack.
In an audacious bit of counterprogramming, the Met is currently staging the longest opera in its repertory, Wagner’s nearly six-hour “Die Meistersinger von Nurnberg.” Even in prepandemic times, the work was a herculean undertaking, requiring an army of more than 400 artists and stagehands, breakneck set changes, spirited fight scenes and two 40-minute intermissions.
“We are providing hope for opera lovers,” Peter Gelb, the Met’s general manager, said in an interview. “To be able to put on an opera like ‘Meistersinger’ is a symbol of the Met’s resolve.”
But it is unclear if audiences will turn out for “Meistersinger” and other operas, which tend to be lengthy, at a time when the Delta variant of the coronavirus remains a concern and when audiences must show proof of vaccination wear masks during performances.
The pandemic also added new levels of complexity to presenting the opera, as singers, orchestra players, dancers and stagehands spent long hours preparing to bring it back to the stage. They are all required to wear masks wherever they go at the Met, except onstage. But once onstage, forget about social distancing: “Meistersinger” demands tender embraces, close-quarter brawls and impassioned singing, often within spitting distance of dozens of people.
Wearing masks during early rehearsals was taxing for some singers. “It’s really torture,” said the baritone Michael Volle, who plays the central role of the shoemaker and poet Hans Sachs. “You can’t breathe freely.”
The Met has made safety a priority, requiring coronavirus tests twice a week for all employees and guest artists. Masks and hand sanitizing stations are ubiquitous. Signs posted backstage remind people to report their symptoms if they feel ill.
Buoyed by shortages in labor and supplies that leave employers more vulnerable, and frustrated by what they see as unfair treatment during the pandemic, many American workers are standing up for a better deal.
Data collected by the School of Industrial and Labor Relations at Cornell University shows that the number of workers on strike across the country increased in October to more than 25,000, compared with an average of around 10,000 over the previous three months.
“Labor market leverage and the fact that workers have been through incredibly difficult working conditions over the past year and a half with the pandemic are combining to explain a lot of this labor activism now,” said Johnnie Kallas, a Ph.D. student and the project director of Cornell’s Labor Action Tracker.
Large companies continue to have considerable power, and it is not clear whether the recent job actions point to a new era of widespread strikes.
Still, the fitful economic recovery from the pandemic has eroded management’s advantages. Many employers are having unusual difficulty in filling jobs — this summer, the Labor Department recorded the highest number of job openings since it began keeping such data in 2000. And for some companies, supply-chain disruptions have taken a toll on the bottom line.
Many workers also contend that their employers have failed to share enormous pandemic-era profits with them, even though the workers sometimes risked their lives to make those earnings possible.
Workers say that when companies do offer raises, the increases are often limited and don’t make up for the weakening of benefits that they have endured for years.
Yet for every force pushing workers toward a strike, there are others that push in the other direction, and some unions that were threatening to strike recently have pulled back from the brink.
Is the Pfizer-BioNTech coronavirus vaccine safe for children ages 5 to 11? Does it work? Does every child need it?
The Food and Drug Administration on Friday authorized the vaccine for emergency use in those age groups, following a near-unanimous recommendation from its advisers last week. On Tuesday, a similar committee advising the Centers for Disease Control and Prevention is meeting to have its say. (The meeting is streaming here.)
If, as expected, the advisers recommend the vaccine and the agency’s director, Dr. Rochelle Walensky, signs off, the decision would most likely ease the worries of millions of parents and buttress the United States’ defenses against the virus before winter arrives.
Inoculations for children ages 5 through 11 could then begin this week. Anticipating the agency’s decision, the Biden administration has enlisted more than 20,000 pediatricians, family doctors and pharmacies to administer the vaccines.
About 15 million doses are already being packed with dry ice, loaded into small specialized containers and shipped via airplanes and trucks to vaccination sites across the country, federal officials said on Monday.
The younger children will receive one-third of the dose authorized for those 12 and older, delivered by smaller needles and stored in smaller vials to avoid a mix-up with adult doses.
The C.D.C.’s guidelines for the vaccine’s use are not legally binding, but heavily influence the medical community’s practice. An endorsement would be timely, as Americans begin to plan for the winter holidays.
Although cases in the United States have been falling steadily for weeks, experts warn that indoor family gatherings during the Thanksgiving and Christmas holidays may send the rates soaring again, even if not to the horrific highs of last year. Airlines are preparing for what may be the busiest travel season since the start of the pandemic.
Vaccinations would ease the minds of many parents who are anxious to protect their young children and frustrated by frequent school shutdowns and quarantines. Outbreaks of the coronavirus forced 2,000 schools to close between early August and October.
Still, many parents are hesitant to immunize their children, citing concerns about long-term safety of the vaccine or because they fear that the vaccine is more harmful than Covid-19.
About three in 10 parents say they will definitely not get the vaccine for their 5- to 11-year-old children, according to the most recent poll by the Kaiser Family Foundation. A similar percentage of parents said that they would immunize their children “right away,” a figure that has barely budged since similar polls in July and September.
Before the F.D.A. advisers met last week, they were bombarded by thousands of emails spouting misinformation about the vaccine and asking the experts to vote against it. One common objection to the vaccine holds that children rarely get sick from the virus, and the vaccine’s potential harms may outweigh its benefits.
But while children are much less likely than adults to become seriously ill from the virus, their risk is not zero. Many children were infected with the coronavirus in the most recent surge, and children ages 5 through 11 accounted for nearly 11 percent of all cases the week of Oct. 10, according to data collected by the C.D.C.
Since the beginning of the pandemic, more than 8,300 children ages 5 to 11 have been hospitalized with Covid, and at least 170 have died. About one-third of the hospitalized children were sick enough to be admitted to intensive care units.
An expert advisory committee to the Centers for Disease Control and Prevention meets on Tuesday to consider whether to vote to recommend Pfizer-BioNTech’s coronavirus vaccine for use in children 5 to 11.
Last week the Food and Drug Administration decided to authorize the vaccine for that age group. Then there are steps at the C.D.C. and at the state level before the 28 million children in the age group could get shots.
Here’s what needs to happen first.
At the C.D.C.
The panel, a group of independent experts called the Advisory Committee on Immunization Practices, considers the F.D.A.’s decision and makes recommendations.
The C.D.C. contemplates the panel’s suggestions, which the agency usually follows.
The C.D.C., which is led by Dr. Rochelle P. Walensky, weighs in with final guidance, which influences how entities like states, hospitals and doctors’ offices distribute vaccines. In September, Dr. Walensky ignored the C.D.C. panel’s advice and recommended booster shots of Pfizer’s vaccine for frontline workers, aligning her agency’s guidance with the F.D.A.’s authorization.
In the states
State health authorities typically adopt the C.D.C.’s guidance, though it is not binding.
Pediatric doses will begin to become available once the regulatory process is done, but the vaccination program will only reach full strength next week, Jeffrey D. Zients, the White House’s pandemic response coordinator, said on Monday.